Koninklijke Philips NVRYLPF +2.21%70 5-Year Yield-on-Cost % is 3.52 as of Jul. 03, 2026, which is 36% above its 10-year median of 2.59. GuruFocus rates RYLPF with a GF Score™ of 70/100 and a GF Value™ of $26.00 (Fairly Valued). The stock has 3 warning signs investors should review. Among 328 Medical Devices & Instruments companies, Koninklijke Philips NV ranks better than 65.24% on this metric.
Koninklijke Philips NV's yield on cost for the quarter that ended in Mar. 2026 was 3.52.
The historical rank and industry rank for Koninklijke Philips NV's 5-Year Yield-on-Cost % or its related term are showing as below:
RYLPF'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.86 Med: 2.59 Max: 6.79
Current: 3.52
During the past 13 years, Koninklijke Philips NV's highest Yield on Cost was 6.79. The lowest was 1.86. And the median was 2.59.
RYLPF's 5-Year Yield-on-Cost % is ranked better than 65.24% of 328
companies
in the Medical Devices & Instruments industry
Industry Median: 2.325
vs RYLPF: 3.52
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Koninklijke Philips NV 5-Year Yield-on-Cost % Related Terms
RYLPF vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Koninklijke Philips NV's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koninklijke Philips NV 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Koninklijke Philips NV's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Koninklijke Philips NV (RYLPF) has a 5-Year Yield-on-Cost % of 3.52 as of Jul. 03, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Koninklijke Philips NV and its competitors. This is 36% above median its historical median of 2.59. Over the past decade, Koninklijke Philips NV's 5-Year Yield-on-Cost % has ranged from 1.86 to 6.79. According to the industry distribution chart, Koninklijke Philips NV ranks #114 out of 328 companies in the Medical Devices & Instruments industry, placing it in the top 34.8%.
Is Koninklijke Philips NV's 5-Year Yield-on-Cost % too high?
Koninklijke Philips NV's current 5-Year Yield-on-Cost % of 3.52 is 36% above median its 10-year median of 2.59. Over the past 10 years, this metric has ranged from a low of 1.86 to a high of 6.79. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.33. Koninklijke Philips NV's value of 3.52 is 51.4% above this industry median. Based on the distribution chart, Koninklijke Philips NV ranks #114 out of 328 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Koninklijke Philips NV has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #114 out of 328 companies for 5-Year Yield-on-Cost %. This puts Koninklijke Philips NV in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.33. Koninklijke Philips NV's value of 3.52 is 51.4% above this benchmark. Historically, Koninklijke Philips NV's own 5-Year Yield-on-Cost % has ranged from 1.86 to 6.79 over the past decade. While the company's 10-year median is 2.59 vs. the industry median of 2.33, Koninklijke Philips NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.33, based on 328 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koninklijke Philips NV's current 5-Year Yield-on-Cost % of 3.52 is 51.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Koninklijke Philips NV and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koninklijke Philips NV's current 5-Year Yield-on-Cost % is 3.52, which is 36% above median its own 10-year median of 2.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $26.00, compared to a current price of $28.01 — trading 7.7% above its estimated fair value. The current 5-Year Yield-on-Cost % is 3.52, which is 36% above median its 10-year median of 2.59 and 51.4% above the Medical Devices & Instruments industry median of 2.33. Koninklijke Philips NV's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current 5-Year Yield-on-Cost % is 3.52 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued.
The current stock price of $28.01 is trading 7.7% above its estimated GF Value™ of $26.00.
GuruFocus considers Koninklijke Philips NV to be Fairly Valued.
Key valuation signals for RYLPF:
5-Year Yield-on-Cost %: 3.52 (36% above median its 10-year median of 2.59)
GF Value™: $26.00 vs. price of $28.01 (7.7% above fair value)
Industry Position: 51.4% above the Medical Devices & Instruments median (#114 of 328)
No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
70GF Score
Get the complete analysis for RYLPF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYLPF has been successfully added to your 